Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. - Wikidata - wikimedia - TriplyDB

Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.

Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.

http://www.wikidata.org/entity/Q33955998

about

Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Viral quasispecies evolution The hepatitis C virus glycan shield and evasion of the humoral immune response Neutralizing antibody response to hepatitis C virus Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission Influence of host resistance on viral adaptation: hepatitis C virus as a case study Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses Protective immunity against hepatitis C: many shades of gray.Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.Immune control and failure in HCV infection--tipping the balance.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes.Will there be a vaccine to prevent HCV infection?Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects.Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance.Adaptive immunity to hepatitis C virus.Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody.Transmission of clonal hepatitis C virus genomes reveals the dominant but transitory role of CD8⁺ T cells in early viral evolution.Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population.Hepatitis C virus infection: establishment of chronicity and liver disease progression Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.Hepatitis C virus infection of neuroepithelioma cell lines.The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design.Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, Challenge Evaluating the ability of the pairwise joint site frequency spectrum to co-estimate selection and demography CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.Hepatitis C virus infection of cholangiocarcinoma cell lines.

P2860

Q26799141-708FDEE3-0E22-47CE-BFD2-0289AB6AE722 Q26801759-112FFE81-41D3-42AC-AA0F-FF0D132EDB1B Q27013917-00EC38AB-E67D-4593-BFC2-D2929CD54F9C Q27023390-EAC263E1-D38D-4685-94EE-709506F7366B Q27027484-E3148E70-33A6-4D80-9961-48D97D9DC953 Q27488844-624C76E7-2B3B-4095-91A4-B73BF568D74A Q27678252-DAB2B1D6-2BAE-4714-91BB-716B02A8A53E Q27684354-70C55191-6C1B-484A-885C-346FC83EB2EB Q28087595-504D6037-C137-4E71-A491-445A7D5D12C8 Q28482493-626F4B71-DD1D-4F50-B87D-73F7DC7E9705 Q28731355-4F2A93B3-B00E-4267-A699-B94FC415E95B Q30383939-DD4CF9C7-4EC8-4E9A-827B-09477284E5B7 Q33631104-4093C50E-D733-467A-A6D4-377207051D1A Q33707246-AA48EFC8-7E93-45A1-A2A8-70E837D080A3 Q33759224-443EC9EE-328D-4E45-B4C7-7562FFF5161E Q33890011-8E5B5517-994D-49CF-9370-F77287ADAB26 Q33929089-0D751D77-BBE1-4F16-B891-4495C32FF295 Q34178628-680A347F-2BBD-4917-89A8-4BA434461478 Q34481429-9DB42D0A-C089-4D6A-A52E-F8FCBA0C8412 Q34504820-1FC55C0D-B74E-4AF3-AB2A-40AD9E1096E7 Q34781537-9E23870E-3E9A-4EF3-A671-7BE1E3B6AB83 Q34969032-3C3DB179-6E8C-4FBD-8236-77C7FA3DB524 Q35111735-021B2BAC-6063-4290-8745-811764715695 Q35242585-E472633C-A25A-4E80-AE53-D25FA6A34DF2 Q35259748-46E5F70F-2127-4C9D-A3D6-94EA228EF216 Q35450992-13676A68-F729-41D8-A1A0-D57AC2AAA67F Q35531150-E87CA376-1741-4EE8-B226-F73B1A12AD33 Q35557115-7FFA9C40-1D97-43B2-B7FB-6D499E4FA3AA Q35633193-C61ADD55-538B-4B6F-A1C3-8EC80D20BC41 Q35728873-33E473EF-76FB-4796-8768-554C793631ED Q35741969-A6E2FCE1-D7D1-4844-95AF-443840C98AD7 Q35787699-9C9EB2A4-8638-4DB0-96AB-40B3F747BDD4 Q35818245-47926588-34BE-4122-B39A-761EA54D2F92 Q35883439-F8D9AE80-79AA-4F95-B89B-776367079B4B Q35899199-FB233DF5-9CF2-4691-A561-E8DAAA134E8E Q35913863-3F078682-1D54-4C15-A21A-5B791A04CBF3 Q35960168-E60086D9-D5FB-45DB-A8DB-C9974B96FD2D Q35993488-7808E4A5-DD1D-418E-A164-1127B91BD78C Q36246646-D4C390C8-7979-4F42-B5FB-AAA799B953CD Q36255097-7A26AA57-35E0-42E3-871A-67E31972F31C

P2860

Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.

http://www.wikidata.org/entity/Q33955998

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Selection pressure from neutra ...... ection with hepatitis C virus.

@ast

Selection pressure from neutra ...... ection with hepatitis C virus.

@en

type

label

Selection pressure from neutra ...... ection with hepatitis C virus.

@ast

Selection pressure from neutra ...... ection with hepatitis C virus.

@en

prefLabel

Selection pressure from neutra ...... ection with hepatitis C virus.

@ast

Selection pressure from neutra ...... ection with hepatitis C virus.

@en

P1433

Q33955998-4C3E00C0-2356-45B7-ACFC-D2381A34922B

P1476

Q33955998-71934B01-B5AA-4214-9444-5CC4D873953C

P2093

Q33955998-7520FE30-AF1C-4C01-A67D-94EB6A61ACCD

Q33955998-AFF7807B-A861-4C4E-8160-74B6F55D2248

Q33955998-E33BB2C9-A18D-4863-9F77-BFDF35891EA5

P2860

Q33955998-0570CBAC-8829-41E4-AEA0-D68391876B69

Q33955998-095124E7-28E1-44DF-B477-B419E50B70A7

Q33955998-1B15101E-B9AE-47F2-9198-D52697CDE233

Q33955998-23EC8957-B7B2-4222-894C-140E65DBF2DC

Q33955998-279721AD-D0BD-45CF-9576-30D1C42A5243

Q33955998-2BFFB322-1206-40FC-8083-099A50B140EE

Q33955998-308C510E-0BB4-4F91-9F53-5265993045B2

Q33955998-35F25EA0-7425-4297-92A0-D28DB623B891

Q33955998-37B662D3-72CE-425A-AC2B-3D25D1DDCA5B

Q33955998-49C3B4B1-CDBF-4A7B-A33C-81364A7D6142

P304

Q33955998-D77D6818-4967-4902-B7FB-58801E5E40ED

P31

Q33955998-37B71C77-7566-409D-B88A-7E8866F7C1A1

P356

Q33955998-EBE81F3C-F14A-442D-BE29-2FBC720B580B

P407

Q33955998-1C53633F-3F7D-4DF9-9D70-A2A204BC3F38

P433

Q33955998-8C1B55F2-1118-4F4F-A6BA-DF21DC881583

P478

Q33955998-66DFC640-2E69-4837-A1A5-FB716CC90653

P50

Q33955998-43A416B5-76CB-499D-A70E-72F979D38B18

Q33955998-BECDB80E-AA74-4FB5-9719-05F6B837A450

P577

Q33955998-1889A255-C285-475A-AE73-067822CF3908

P5875

Q33955998-249B40CA-D103-46E6-B660-BF156B62D3F9

P698

Q33955998-D1AC1B7D-0AF3-4634-938F-FDA74E9BB407

P921

Q33955998-216F546F-5F6C-4718-A874-AD009BE55879

P932

Q33955998-31A13EC2-00A3-4261-A514-96BF552F538C

P356

J.GASTRO.2009.02.080

P1433

Gastroenterology

P1476

Selection pressure from neutra ...... ection with hepatitis C virus.

@en

P2093

Andrea L Cox

http://www.w3.org/2001/XMLSchema#string

Dale M Netski

http://www.w3.org/2001/XMLSchema#string

Xiao-Hong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of hepatitis C virus infection

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Cellular immune responses against hepatitis C virus: the evidence base 2002

Divergent and convergent evolution after a common-source outbreak of hepatitis C virus

Cellular immune selection with hepatitis C virus persistence in humans

Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level

P304

2377-2386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2009.02.080

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P50

Kimberly A Dowd

P577

2009-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24216627

http://www.w3.org/2001/XMLSchema#string

P698

19303013

http://www.w3.org/2001/XMLSchema#string

P921

P932

2895772

http://www.w3.org/2001/XMLSchema#string